149 related articles for article (PubMed ID: 32305096)
1. Familial Hypercholesterolemia and Atherosclerosis: Animal Models and Therapeutic Advances.
Xu S; Weng J
Trends Endocrinol Metab; 2020 May; 31(5):331-333. PubMed ID: 32305096
[TBL] [Abstract][Full Text] [Related]
2. Exosome-based
Li Z; Zhao P; Zhang Y; Wang J; Wang C; Liu Y; Yang G; Yuan L
Theranostics; 2021; 11(6):2953-2965. PubMed ID: 33456582
[TBL] [Abstract][Full Text] [Related]
3. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
[TBL] [Abstract][Full Text] [Related]
4. LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis.
Guo X; Gao M; Wang Y; Lin X; Yang L; Cong N; An X; Wang F; Qu K; Yu L; Wang Y; Wang J; Zhu H; Xian X; Liu G
EBioMedicine; 2018 Jan; 27():214-224. PubMed ID: 29289533
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for familial hypercholesterolemia.
Van Craeyveld E; Jacobs F; Gordts SC; De Geest B
Curr Pharm Des; 2011; 17(24):2575-91. PubMed ID: 21774774
[TBL] [Abstract][Full Text] [Related]
6. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (
Burke AC; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Barrett PHR; Newton RS; Pickering JG; Huff MW
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1178-1190. PubMed ID: 29449335
[TBL] [Abstract][Full Text] [Related]
7. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
[TBL] [Abstract][Full Text] [Related]
9. Recapitulating familial hypercholesterolemia in a mouse model by knock-in patient-specific LDLR mutation.
Liu J; Yang F; Shang L; Cai S; Wu Y; Liu Y; Zhang L; Fei C; Wang M; Gu F
FASEB J; 2024 Mar; 38(6):e23573. PubMed ID: 38526846
[TBL] [Abstract][Full Text] [Related]
10. Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.
Soufi M; Kurt B; Schweer H; Sattler AM; Klaus G; Zschocke J; Schaefer JR
Atheroscler Suppl; 2009 Dec; 10(5):5-11. PubMed ID: 20129366
[TBL] [Abstract][Full Text] [Related]
11. Software and database for the analysis of mutations in the human LDL receptor gene.
Varret M; Rabès JP; Collod-Béroud G; Junien C; Boileau C; Béroud C
Nucleic Acids Res; 1997 Jan; 25(1):172-80. PubMed ID: 9016531
[TBL] [Abstract][Full Text] [Related]
12. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
[TBL] [Abstract][Full Text] [Related]
13. Type of LDLR mutation and the pharmacogenetics of familial hypercholesterolemia treatment.
Santos PC; Pereira AC
Pharmacogenomics; 2015; 16(15):1743-50. PubMed ID: 26427613
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis.
Shin DG; Han SM; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo JT; Hur SH; Jeong JO; Jang Y; Lee JH; Lee SH
Atherosclerosis; 2015 Nov; 243(1):53-8. PubMed ID: 26343872
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
[TBL] [Abstract][Full Text] [Related]
17. Macrophages of genetically characterized familial hypercholesterolaemia patients show up-regulation of LDL-receptor-related proteins.
Escate R; Padro T; Borrell-Pages M; Suades R; Aledo R; Mata P; Badimon L
J Cell Mol Med; 2017 Mar; 21(3):487-499. PubMed ID: 27680891
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans.
Thompson GR
Atherosclerosis; 2018 Sep; 276():148-154. PubMed ID: 30064057
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.
Kassim SH; Li H; Vandenberghe LH; Hinderer C; Bell P; Marchadier D; Wilson A; Cromley D; Redon V; Yu H; Wilson JM; Rader DJ
PLoS One; 2010 Oct; 5(10):e13424. PubMed ID: 20976059
[TBL] [Abstract][Full Text] [Related]
20. [Familial hypercholesterolemia in Tunisia].
Jelassi A; Jguirim I; Najah M; Maatouk F; Ben Hamda K; Slimane MN
Pathol Biol (Paris); 2009 Jul; 57(5):444-50. PubMed ID: 19041195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
